Diagnosing respiratory infections presents a complex challenge for healthcare providers. Symptoms like cough, fever, and shortness of breath often overlap, obscuring the true causative pathogen. In a critical healthcare environment where time is of the essence, traditional culture methods fall short in speed and sensitivity. This not only delays effective treatment but also contributes to the larger issue of antimicrobial resistance, exacerbated by misdiagnoses or late diagnoses.
CoreBioLabs precisely analyzes RNA/DNA for 29 viral pathogens and 17 bacterial pathogens simultaneously using advanced molecular identification techniques with the QuantStudio 12 Flex by ThermoFisher®.
Resistance Markers:
CoreBioLabs offers a revolutionary PCR testing platform. Our advanced testing method is not just an alternative; it’s a leap forward in precision diagnostics:
At CoreBioLabs, we understand these challenges and offer a solution that meets the urgency and precision required in respiratory pathogen diagnosis. Our state-of-the-art PCR (Polymerase Chain Reaction) testing services revolutionize the way respiratory infections are identified:
Embrace the future of respiratory infection diagnostics with CoreBioLabs. Our PCR testing services not only provide accuracy and speed but also contribute to better patient outcomes and global health initiatives. Join us in the fight against respiratory pathogens and antimicrobial resistance. Choose precision; choose CoreBioLabs.